Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis
Open Access
- 28 April 2009
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 127
- https://doi.org/10.1186/1471-2407-9-127
Abstract
Our purpose was to collect preliminary data on newly diagnosed breast cancer patient knowledge of prognosis before and after oncology visits. Many oncologists use a validated prognostic software model, Adjuvant!, to estimate 10-year recurrence and mortality outcomes for breast cancer local and adjuvant therapy. Some oncologists are printing Adjuvant! screens to use as visual aids during consultations. No study has reported how such use of Adjuvant! printouts affects patient knowledge of prognosis. We hypothesized that Adjuvant! printouts would be associated with significant changes in the proportion of patients with accurate understanding of local therapy prognosis.Keywords
This publication has 23 references indexed in Scilit:
- Assessing risk communication in breast cancer: Are continuous measures of patient knowledge better than categorical?Patient Education and Counseling, 2009
- Improving understanding of adjuvant therapy options by using simpler risk graphicsCancer, 2008
- Risk communication with patients with breast cancer: cautionary notes about printing Adjuvant! estimatesThe Lancet Oncology, 2008
- Numeric, Verbal, and Visual Formats of Conveying Health Risks: Suggested Best Practices and Future RecommendationsMedical Decision Making, 2007
- Cognitive function in breast cancer patients prior to adjuvant treatmentBreast Cancer Research and Treatment, 2007
- A decision aid to assist in adjuvant therapy choices for breast cancerPsycho‐Oncology, 2006
- Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk InformationMedical Decision Making, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Strategies to help patients understand risksBMJ, 2003
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998